Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Sigma-Tau describes novel HSP 90 inhibitor

April 17, 2014

Phase I results for MRX-34, a first-in-class liposome formulated miR-34 mimic

April 17, 2014

Novel putative antisense mitochondrial RNA-based therapy for renal cell carcinoma

April 16, 2014

TT-genotype of IL-23R has protective effect in lung transplant recipients

April 16, 2014

Ace2 gene therapy reduces liver fibrosis in mice

April 16, 2014

Germline PIGA mutations linked to new genetic syndrome

April 16, 2014

AQP-5 expression and polymorphisms predict early breast cancer survival

April 16, 2014

Janssen presents novel FASN inhibitors for the treatment of cancer

April 16, 2014

Molecular Templates presents novel therapeutic candidate for multiple myeloma

April 16, 2014

Peginterferon alfa-2b follow-on biologic is noninferior in phase II/III trial

April 15, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...